Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity

Journal of Muscle Research and Cell Motility

Volumn 27, Issue 1, 2006, Pages 83-92

  Sabbatini, Antonietta R M ^a   Toscano, Antonio ^b   Aguennouz, Mohammed ^b   Martini, Daniela ^a   Polizzi, Enza ^a   Ranieri Raggi, Maria ^a   Moir, Arthur J G ^c   Migliorato, Alba ^b   Musumeci, Olimpia ^b   Vita, Giuseppe ^b   Raggi, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; ISOPROTEIN; POLYPEPTIDE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MUSCLE BIOPSY; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; SKELETAL MUSCLE; WESTERN BLOTTING;

ADULT; AGED; AMP DEAMINASE; ANTIBODIES; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; PEPTIDES; PROTEINS;

EID: 33746089545     PISSN: 01424319     EISSN: 15732657     Source Type: Journal    
DOI: 10.1007/s10974-006-9059-4     Document Type: Article

References (43)

1. Banker BQ and Engel AG (2004) Basic reactions of muscle. In: Engel AG and Franzini-Armstrong C (eds) Myology: Basic and Clinical 3rd edn. (pp. 691-747). Mc Graw-Hill, New York.
2. Bausch-Jurken MT, Mahnke-Zizelman DK, Morisaki T and Sabina RL (1992) Molecular cloning of AMP deaminase isoform L. J Biol Chem 267: 22407-22413.
3. Bruno C, Minetti C., Shanske S, Morreale G, Bado M, Cordone G and DiMauro S (1998) Combined defects of muscle phosphofructokinase and AMP deaminase in a child with myoglobinuria. Neurology 50: 296-298.
4. Chapman AG and Atkinson DE (1973) Stabilization of adenylate energy charge by the adenylate deaminase reaction. J Biol Chem 248: 8309-8312.
5. Dubowitz V and Brooke MH (1973) Muscle Biopsy: A Modern Approach. Saunders, London. Philadelphia, Toronto.
6. Fishbein WN, Armbrustmacher VW and Griffin JL (1978) Myoadenylate deaminase deficiency: a new disease of muscle. Science 200: 545-548.
7. Fishbein WN, Griffin JL and Armbrustmacher VW (1980) Stain for skeletal muscle adenylate deaminase. Arch Pathol Lab Med 104: 462-466.
8. Fishbein WN (1985) Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med 33: 158-169.
9. Fishbein WN, Sabina RL, Ogasawara N and Holmes EW (1993) Immunologic evidence for three isoforms of AMP deaminase (AMPD) in mature skeletal muscle. Biochim Biophys Acta 1163: 97-104.
10. Fortuin FD, Morisaki T and Holmes EW (1996) Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle. Proc Assoc Am Physicians 108: 329-333.
11. Hayes DJ, Summers BA and Morgan-Hughes JA (1982) Myoadenylate deaminase deficiency or not? Observations on two brothers with exercise-induced muscle pain. J Neurol Sci 53: 125-136.
12. Husic DH and Suelter CH (1984) Circulatory clearance, internalization and degradation of muscle AMP aminohydrolase. J Biol Chem 259: 4359-4364.
13. Jones AL, Hulett MD and Parish CR (2005) Histidine-rich glycoprotein: a novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol 83: 106-118.
14. Koide T and Odani S (1987) Histidine-rich glycoprotein is evolutionarily related to the cystatin superfamily. FEBS Lett 216: 17-21.
15. Lamb AL, Torres AS, O'Halloran TV and Rosenzweig AC (2001) Heterodimeric structure of superoxide dismutase in complex with its metallochaperone. Nat Struct Bio 8: 751-755.
16. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE and Goldberg AL (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39-51.
17. Lijnen HR, Hoylaerts M and Collen D (1983) Heparin binding properties of human histidine-rich glycoprotein. J Biol Chem 258: 3803-3808.
18. Lowenstein JM (1972) Ammonia production in muscle and other tissues: the purine nucleotide cycle. Physiol Rev 52: 382-414.
19. Lowenstein JM and Tornheim K (1971) Ammonia production in muscle: the purine nucleotide cycle. Science 171: 397-400.
20. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
21. Mahnke-Zizelman DK and Sabina RL (1992) Cloning of human AMP deaminase isoform E cDNAs. J Biol Chem 267: 20866-20877.
22. Mahnke-Zizelman DK, Tullson PC and Sabina RL (1998) Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms. J Biol Chem 273: 35118-35125.
23. Mangani S, Meyer-Klaucke W, Moir AJG, Ranieri-Raggi M, Martini D and Raggi A (2003) Characterization of the zinc-binding site of the histidine-proline-rich glycoprotein associated with rabbit skeletal muscle AMP deaminase. J Biol Chem 278: 3176-3184.
24. Martini D, Montali U, Ranieri-Raggi M, Sabbatini ARM, Thorpe SJ, Moir AJG and Raggi A (2004) A calpain-like proteolytic activity produces the limited cleavage at the N-terminal regulatory domain of rabbit skeletal muscle AMP deaminase: evidence of a protective molecular mechanism. Biochim Biophys Acta 1702: 191-198.
25. McKinney MM and Parkinson A (1987) A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid. J Immunol Methods 96: 271-278.
26. Morisaki T, Sabina RL and Holmes EW (1990) Adenylate deaminase: A multigene family in humans and rats. J Biol Chem 265: 11482-11486.
27. Morisaki T, Gross M, Morisaki H, Pongratz D, Zöllner N and Holmes EW (1992) Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA 89: 6457-6461.
28. Raggi A, Ronca-Testoni S and Ronca G (1969) Muscle AMP aminohydrolase. II. Distribution of AMP aminohydrolase, myokinase and creatine kinase activities in skeletal muscle. Biochim Biophys Acta 178: 619-622.
29. Raggi A, Bergamini C and Ronca G (1975) Isozymes of AMP deaminase in red and white skeletal muscles. FEBS Lett 58: 19-23.
30. Ranieri-Raggi M, Montali U, Ronca F, Sabbatini ARM, Brown PE, Moir AG and Raggi A (1997) Association of purified skeletal-muscle AMP deaminase with a histidine-proline-rich-glycoprotein-like molecole. Biochem J 326: 641-648.
31. Ranieri-Raggi M, Martini D, Sabbatini ARM, Moir AJG and Raggi A (2003) Isolation by zinc-affinity chromatography of the histidine-proline-rich glycoprotein molecule associated with rabbit skeletal muscle AMP deaminase. Evidence that the formation of a protein-protein complex between the catalytic subunit and the novel component is critical for the stability of the enzyme. Biochim Biophys Acta 1645: 81-88.
32. Ren J and Holloszy O (1992) Adaptation of rat skeletal muscle to creatine depletion: AMP deaminase and AMP deamination. J Appl Physiol 73: 2713-2716.
33. Ronca F, Ranieri-Raggi M, Brown PE, Moir AJG and Raggi A (1994) Evidence of a species-differentiated regulatory domain within the N-terminal region of skeletal muscle AMP deaminase. Biochim Biophys Acta 1209: 123-129.
34. Sabbatini ARM, Ranieri-Raggi M, Pollina L, Viacava P, Ashby JR, Moir AJG and Raggi A (1999) Presence in human skeletal muscle of an AMP deaminase-associated protein that reacts with an antibody to human plasma histidine-proline-rich glycoprotein. J Histochem Cytochem 47: 255-260.
35. Sabina RL and Holmes EW (2001) Myoadenylate deaminase deficiency. In: Scriver CR (ed) The Metabolic and Molecular Bases of Inherited Disease (pp. 2627-2638). Mc Graw-Hill, New York.
36. Sinkeler SP, Joosten EM, Wevers RA, Oei TL, Jacobs AE, Veerkamp JH and Hamel BC (1988) Myoadenylate deaminase deficiency: a clinical, genetic, and biochemical study in nine families. Muscle Nerve 11: 312-317.
37. Tarnopolsky MA, Parise G, Gibala MJ, Graham TE and Rush JW (2001) Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans. J Physiol 533: 881-889.
38. Thompson JL, Sabina RL, Ogasawara N and Riley DA (1992) AMP deaminase histochemical activity and immunofluorescent isozyme localisation in rat skeletal muscle. J Histochem Cytochem 40: 931-946.
39. Tullson PC and Terjung RL (1991) Adenine nucleotide metabolism in contracting skeletal muscle. Exerc Sport Sci Rev 19: 507-537.
40. Van Kuppevelt TH, Veerkamp JH, Fishbein WN, Ogasawara N and Sabina RL (1994) Immunolocalization of AMP-deaminase isozymes in human skeletal muscle and cultured muscle cells: concentration of isoforms M at the neuromuscular junction. J Histochem Cytochem 42: 861-868.
41. Verzijl HT, van Engelen BG, Luyten JA, Steenbergen GC, van den Heuvel LP, ter Laak HJ, Padberg GW and Wevers RA (1998) Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol 44: 140-143.
42. Winder WW, Terjung RL, Baldwin KM and Holloszy JO (1974) Effects of exercise on AMP deaminase and adenylosuccinase in rat skeletal muscle. Am J Physiol 227: 1411-1414.
43. Zielke CL and Suelter CH (1971) Rabbit muscle adenosine 5′-monophosphate aminohydrolase. Characterization as a zinc metalloenzyme. J Biol Chem 246: 2179-2186.